This study highlights the importance of SHIP-1 as a potential tumor suppressor that regulates immunosuppressive MDSC and TAM development and function, which impact anti-tumor immune responses in PC pre-clinical models. This evidence concerns the gene INPP5D and pachyonychia congenita.